Parallel Advisors’s ARS Pharmaceuticals SPRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-38
| Closed | -$478 | – | 3667 |
|
|
2025
Q1 | $478 | Buy |
38
+21
| +124% | +$264 | ﹤0.01% | 3229 |
|
|
2024
Q4 | $179 | Buy |
+17
| New | +$179 | ﹤0.01% | 3372 |
|
|
2023
Q4 | – | Sell |
-151
| Closed | -$571 | – | 3462 |
|
|
2023
Q3 | $571 | Buy |
+151
| New | +$571 | ﹤0.01% | 3081 |
|
|
2023
Q2 | – | Sell |
-45
| Closed | -$293 | – | 3509 |
|
|
2023
Q1 | $293 | Sell |
45
-863
| -95% | -$5.62K | ﹤0.01% | 3236 |
|
|
2022
Q4 | $7.75K | Hold |
908
| – | – | ﹤0.01% | 2137 |
|
|
2022
Q3 | $5K | Hold |
908
| – | – | ﹤0.01% | 2298 |
|
|
2022
Q2 | $4K | Buy |
+908
| New | +$4K | ﹤0.01% | 2362 |
|
|
2021
Q3 | – | Sell |
-415
| Closed | -$13K | – | 3219 |
|
|
2021
Q2 | $13K | Hold |
415
| – | – | ﹤0.01% | 1885 |
|
|
2021
Q1 | $18K | Buy |
415
+250
| +152% | +$10.8K | ﹤0.01% | 1633 |
|
|
2020
Q4 | $8K | Buy |
+165
| New | +$8K | ﹤0.01% | 1870 |
|